Cleerly's AI scans comparable to gold-standard angiography
Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.
To reduce heart attack rates, make CCTA the new standard of care.
By James K. Min
To improve heart attack prevention, there is an urgent unmet need to modernize our approach from late-stage symptom-driven care to direct disease-based care, a care paradigm that addresses heart attack risk in all patients across the entire continuum of heart disease severity.
When it comes to identifying and intervening against heart disease, waiting for a patient to present with chest pain is akin to waiting for someone to develop advanced cancer rather than pinpointing it earlier when treatments may be more effective. While waiting for late-stage disease is not an ideal preventive approach, this approach has nevertheless represented the historical standard of heart disease care for decades.
Our approach to heart disease has been ineffective, with a person dying of heart disease every 1.7 seconds, and with more than half of all heart attacks occurring in individuals who experience no symptoms before the catastrophic event takes place.
See full article HERE.
Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease.
Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall Wellness